Eurobio Scientific launches its COVID antigen self-test

NEXT STORY
Novartis 177Lu-PSMA-617 significantly improves overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer in Phase III VISION study
PREV STORY
BriaCell Therapeutics Corp. Announces US$27.2 Million Private Placement
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rexahn Pharmaceuticals Announces Retirement of its Founder, Chang Ahn, Ph.D., from the Board of Directors

ROCKVILLE, Md., Sept. 01, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a ...

author_avatar
NASDAQ Market News

Shire plc : Director Declaration

Director Declaration July 25, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") ...

author_avatar
NASDAQ Market News

Biosensors Market size set to exceed $29bn by 2024: Global Market Insights Inc.

Ocean View, Delaware, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Biosensors Market size is estimated ...

author_avatar
NASDAQ Market News